CausalSentinel

Protein Dossier — IL11RA (Interleukin-11 receptor subunit alpha)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hypertension -0.057 0.0172 9.42e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: pneumothorax 0.735 0.24 0.00221 Wald ratio 1 cis NA
Cigarettes smoked per day -1.71 0.597 0.00424 Wald ratio 1 cis NA
Multiple sclerosis -0.192 0.0703 0.00638 Wald ratio 1 cis NA
Ulcerative colitis 0.142 0.0526 0.00705 Wald ratio 1 cis NA
Non-cancer illness code self-reported: enlarged prostate -0.28 0.11 0.0105 Wald ratio 1 cis NA
PGC cross-disorder traits 0.126 0.0494 0.0106 Wald ratio 1 cis NA
Cough on most days -0.137 0.0559 0.0145 Wald ratio 1 cis NA
Body mass index (BMI) -0.0226 0.00954 0.0177 Wald ratio 1 cis NA
Non-cancer illness code self-reported: anxiety or panic attacks 0.165 0.0701 0.0184 Wald ratio 1 cis NA
Fractured bone site(s): Arm 0.187 0.0803 0.0202 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) 0.0191 0.00826 0.0209 Wald ratio 1 cis NA
…and 111 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3814_63_1 IL-11 RA Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

9 association rows across 8 traits (8 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Interleukin-11 receptor subunit alpha levels 6e-99 rs11575578 1 GCST90248029 no MR -> candidate analysis
Interleukin-11 receptor subunit alpha levels (IL11RA.3814.63 4e-26 rs11575578 1 GCST90241586 no MR -> candidate analysis
C-C motif chemokine 27 levels 5e-22 rs2812357 1 GCST90059913 no MR -> candidate analysis
Height 9e-14 rs11575580 2 GCST007841 MR: beta=-0.0188, p=0.241 (cis)
Circulating MEPE levels 9e-13 rs11575580 1 GCST90859653 no MR -> candidate analysis
MEPE protein levels 1e-12 rs11575580 1 GCST90469889 no MR -> candidate analysis
Body shape phenotype PC2 3e-11 rs11575580 1 GCST90832990 no MR -> candidate analysis
Height (baseline) 5e-9 rs11575580 1 GCST90565843 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 200 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
craniosynostosis and dental anomalies 0.843 established (curated) no MR -> candidate analysis
craniosynostosis 0.596 established (curated) no MR -> candidate analysis
protozoa infectious disease 0.293 common-variant locus no MR -> candidate analysis
asthma 0.112 common-variant locus MR: beta=-0.0435, p=0.12 (cis)

Of the 4 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (Interleukin-11 receptor subunit alpha)
gnomAD constraint pLI=4.5e-16, LOEUF=1.13 — LoF-tolerant
GWAS Catalog 63 unique SNPs / 126 rows
ClinVar 215 records; 6 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance